Vaginal News and Research

RSS

New study shows some women don't stick to recommended treatment for breast cancer

One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of Michigan Comprehensive Cancer Center researchers.

10 Apr 2013

Reformulated version of anti-HIV gel safe for HIV-negative men and women

A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published today in PLOS ONE.

4 Apr 2013

LSUHSC researchers study common STI

Research led by David H. Martin, MD, Professor and Chief of Infectious Diseases at LSU Health Sciences Center New Orleans, has found that a common sexually transmitted infection-causing parasite "cultivates" bacteria beneficial to it, changing thinking about which comes first-infection or bacteria.

3 Apr 2013

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

The U.S. Food and Drug Administration today approved Invokana (canaglifozin) tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes.

30 Mar 2013

FDA approves Teva's Quartette tablets for prevention of pregnancy

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets for the prevention of pregnancy.

30 Mar 2013

Research shows immune system can destroy HIV through deactivation of vif gene

Human cells have an intrinsic capacity to destroy HIV. However, the virus has evolved to contain a gene that blocks this ability. When this gene is removed from the virus, the innate human immune system destroys HIV by mutating it to the point where it can no longer survive.

29 Mar 2013

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Shionogi Limited, the London-based European subsidiary of Shionogi & Co., Ltd announced today that on 26th March 2013 the European Medicines Agency accepted its Marketing Authorisation Application submission for ospemifene for the treatment of vulvar and vaginal atrophy in post-menopausal women.

27 Mar 2013

Study suggests possibility of engineering artificial ovaries in lab

A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for women.

27 Mar 2013

Certain strains of lactobacillus bacteria can dampen production of toxic shock syndrome toxin 1

Certain Streptococci increase their production of toxic shock syndrome toxin 1, sometimes to potentially dangerous levels, when aerobic bacteria are present in the vagina. But scientists from the University of Western Ontario have discovered certain strains of lactobacillus bacteria are capable of dampening production of that toxin according to research published in the journal Applied and Environmental Microbiology.

25 Mar 2013

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

30 years into the HIV epidemic, there is no vaccine in sight. Yet, even though there are fantastic and effective cheap and universally available drugs, and a treatment as prevention strategy is known to work, people do not wish to get tested for HIV! If everyone got tested, and treated, we could have brought the infection under control a long time ago!

21 Mar 2013

Independent maternal demographic factors can predict likelihood of operative births in UK: Study

Independent maternal demographic factors such as social status, ethnicity and maternal age can predict the likelihood of operative births in the UK, according to a new study published today (20 March) in BJOG: An International Journal of Obstetrics and Gynaecology.

21 Mar 2013

Study evaluates mesh-related complications for surgical management of female POP

Younger age, less prominent prolapse and concomitant hysterectomies are associated with a higher risk of peri-operative and mesh-related complications after prolapse repair with trocar-guided transvaginal mesh, according to a study presented by a Russian group at the 28th Annual EAU Congress.

21 Mar 2013

Hepatitis C virus rarely transmitted through sex between monogamous heterosexuals

Individuals infected by the hepatitis C virus (HCV) have nothing to fear from sex in a monogamous, heterosexual relationship. Transmission of HCV from an infected partner during sex is rare according to new research published in the March issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD).

19 Mar 2013

Survey shows active women are more likely to prefer midwifery care and planned home birth

Women who see themselves as active participants in the delivery of their first child, and prefer a collaborative role with their healthcare provider are more likely to prefer planned home birth and the care of a midwife, according to a new survey conducted by Columbia University School of Nursing's Adriana Arcia, PhD, RN, and published in the journal Midwifery.

15 Mar 2013

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

Completion rates for the human papillomavirus (HPV) vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public vaccine financing programs are needed, according to new research from the University of Texas Medical Branch (UTMB).

15 Mar 2013

Listen to women's needs when designing HIV prevention strategies

According to "results from a large HIV prevention trial among African women" known as VOICE and released last week, "none of the prevention methods tested in the study made a difference in HIV infection rates, because few women actually used them as directed," AVAC Executive Director Mitchell Warren writes in an opinion piece published in the Huffington Post's "Global Motherhood" blog.

12 Mar 2013

Vaginal News and Research

New study shows some women don't stick to recommended treatment for breast cancer

Reformulated version of anti-HIV gel safe for HIV-negative men and women

LSUHSC researchers study common STI

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

FDA approves Teva's Quartette tablets for prevention of pregnancy

Research shows immune system can destroy HIV through deactivation of vif gene

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Study suggests possibility of engineering artificial ovaries in lab

Certain strains of lactobacillus bacteria can dampen production of toxic shock syndrome toxin 1

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

Independent maternal demographic factors can predict likelihood of operative births in UK: Study

Study evaluates mesh-related complications for surgical management of female POP

Hepatitis C virus rarely transmitted through sex between monogamous heterosexuals

Survey shows active women are more likely to prefer midwifery care and planned home birth

Completion rates for HPV vaccine series continue to remain low, say UTMB researchers

Listen to women's needs when designing HIV prevention strategies

Einstein researchers to develop drug-impregnated intravaginal ring for HIV prevention in women

Melittin-loaded nanoparticles can destroy human immunodeficiency virus

Across the nation, C-section rates show wide variation

Study: Hospital cesarean rates vary widely across U.S. hospitals

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News